Category Archives: Healthcare

H.C. Wainwright Keeps a Buy Rating on HTG Molecular Diagnostics (HTGM)

H.C. Wainwright analyst Yi Chen reiterated a Buy rating on HTG Molecular Diagnostics (HTGM – Research Report) today and set a price target of $2.00. The company’s shares closed last Monday at $0.66, close to its 52-week low of $0.56.

H.C. Wainwright Reiterates Their Buy Rating on Kala Pharmaceuticals (KALA)

In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on Kala Pharmaceuticals (KALA – Research Report), with a price target of $10.00. The company’s shares closed last Monday at $6.52. According to TipRanks.com, Chen is

H.C. Wainwright Reiterates a Buy Rating on CareDx (CDNA)

H.C. Wainwright analyst Yi Chen reiterated a Buy rating on CareDx (CDNA – Research Report) today and set a price target of $43.00. The company’s shares closed last Monday at $23.61. According to TipRanks.com, Chen is a 3-star analyst with

H.C. Wainwright Reiterates Their Buy Rating on Rockwell Med (RMTI)

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Rockwell Med (RMTI – Research Report), with a price target of $11.00. The company’s shares closed last Monday at $2.60, close to its 52-week low

H.C. Wainwright Remains a Buy on ObsEva SA (OBSV)

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on ObsEva SA (OBSV – Research Report) today and set a price target of $40.00. The company’s shares closed last Monday at $3.80, close to its 52-week low of $2.37. According

Analysts Offer Insights on Healthcare Companies: Precision BioSciences (NASDAQ: DTIL) and Ironwood Pharma (NASDAQ: IRWD)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Precision BioSciences (DTIL – Research Report) and Ironwood Pharma (IRWD – Research Report). Precision BioSciences (DTIL) H.C. Wainwright analyst Debjit Chattopadhyay reiterated a